GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $827,000 | -1.5% | 19,007 | -1.5% | 0.03% | +17.9% |
Q1 2022 | $840,000 | -5.2% | 19,288 | -3.9% | 0.03% | 0.0% |
Q4 2021 | $886,000 | +2.0% | 20,080 | -11.7% | 0.03% | -6.7% |
Q3 2021 | $869,000 | +17.0% | 22,731 | +21.8% | 0.03% | +15.4% |
Q2 2021 | $743,000 | +25.7% | 18,658 | +12.7% | 0.03% | +18.2% |
Q1 2021 | $591,000 | +10.3% | 16,560 | +13.6% | 0.02% | -8.3% |
Q4 2020 | $536,000 | +12.1% | 14,578 | +14.9% | 0.02% | -4.0% |
Q3 2020 | $478,000 | +1.3% | 12,689 | +9.7% | 0.02% | -3.8% |
Q2 2020 | $472,000 | +19.2% | 11,572 | +10.6% | 0.03% | -7.1% |
Q1 2020 | $396,000 | -2.9% | 10,464 | +20.4% | 0.03% | +21.7% |
Q4 2019 | $408,000 | +14.9% | 8,688 | +4.4% | 0.02% | +9.5% |
Q3 2019 | $355,000 | +12.0% | 8,325 | +5.1% | 0.02% | +10.5% |
Q2 2019 | $317,000 | +21.0% | 7,918 | +26.4% | 0.02% | +18.8% |
Q1 2019 | $262,000 | +13.9% | 6,266 | +4.0% | 0.02% | 0.0% |
Q4 2018 | $230,000 | -1.3% | 6,025 | +4.0% | 0.02% | +14.3% |
Q3 2018 | $233,000 | +2.6% | 5,792 | +2.7% | 0.01% | 0.0% |
Q2 2018 | $227,000 | – | 5,642 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |